– A 92% SVR35 and a 67% TSS50 were Observed in the Efficacy Evaluable Patients at Week 24 – – 57% of Transfusion Independent Patients Achieved Hemoglobin Stabilization – – Company to Host Investor and Analyst Webcast Featuring Key Opinion Leaders Today at 8:30 a.m. ET – NEWTON, Mass., Dec….